• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.
Rchr
J-GLOBAL ID:202001007221355874   Update date: Mar. 03, 2025

Yamamoto Tatsuro

ヤマモト タツロウ | Yamamoto Tatsuro
Affiliation and department:
Research theme for competitive and other funds  (4):
  • 2024 - 2026 難治性口腔がんの高次エピゲノムを標的とした新規診断・治療法の開発
  • 2019 - 2021 非コードRNAによる転写活性なクロマチン高次構造形成機構の解明
  • 2017 - 2019 Creation of new diagnostic methods and epigenome therapy for oral cancer based on extracellular environment responsive epigenome analysis
  • 2016 - 2019 The active chromatin domain that is regulated by the non-coding RNAs in recurrent breast cancer
Papers (19):
  • Kenji Watanabe, Tatsuro Yamamoto, Tomoko Fujita, Shinjiro Hino, Yuko Hino, Kanami Yamazaki, Yoshimi Ohashi, Shun Sakuraba, Hidetoshi Kono, Mitsuyoshi Nakao, et al. Metabolically inducing defects in DNA repair sensitizes BRCA -wild-type cancer cells to replication stress. Science Signaling. 2024. 17. 862
  • Hisashi Takeshita, Ryoji Yoshida, Manabu Maeshiro, Tatsuro Yamamoto, Toru Oyama, Rin Liu, Kazutoshi Ota, Masanori Shinohara, Hideki Nakayama. True facial artery aneurysm of the submandibular region: A rare case report. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2024. 36. 6. 850-854
  • Kohei Ishikawa, Yuichiro Matsuoka, Kosuke Shinohara, Junki Inoue, Hiromu Yano, Takafumi Eto, Tatsuro Yamamoto, Keisuke Yamana, Shunsuke Gohara, Hisashi Takeshita, et al. Involvement of ferroptosis-defensive xCT/GPX4 axis in radioresistance and its impacts on prognosis in oral squamous cell carcinoma. Oral Science International. 2024
  • Hidefumi Suzuki, Ryota Abe, Miho Shimada, Tomonori Hirose, Hiroko Hirose, Keisuke Noguchi, Yoko Ike, Nanami Yasui, Kazuki Furugori, Yuki Yamaguchi, et al. The 3′ Pol II pausing at replication-dependent histone genes is regulated by Mediator through Cajal bodies’ association with histone locus bodies. Nature Communications. 2022. 13. 1. 2905-2905
  • Scott Maynard, Arnaldur Hall, Panagiotis Galanos, Salvatore Rizza, Tatsuro Yamamoto, Helena Hagner Gram, Sebastian H N Munk, Muhammad Shoaib, Claus Storgaard Sørensen, Vilhelm A Bohr, et al. Lamin A/C impairments cause mitochondrial dysfunction by attenuating PGC1α and the NAMPT-NAD+ pathway. Nucleic acids research. 2022. 50. 17. 9948-9965
more...
MISC (17):
  • 山本 達郎, 福岡 恵, 斉藤 典子. 【エピジェネティクスと疾患】クロマチン高次構造. 医学のあゆみ. 2020. 272. 1. 23-29
  • 山本 達郎, 中山 秀樹, 中尾 光善, 斉藤 典子. 乳がん細胞のエレノアクロマチンドメインは非コードRNAとクロマチン相互作用により制御される(The Eleanor chromatin domain is regulated by chromatin interactions and non-coding RNAs in breast cancer cells). 日本癌学会総会記事. 2019. 78回. P-3055
  • 永尾 優果, 廣末 晃之, 山本 達郎, 坂田 純基, 中元 雅史, 松岡 祐一郎, 有田 英生, 中嶋 光, 川原 健太, 吉田 遼司, et al. BRD4はエピジェネティックな制御を介して口腔扁平上皮癌の高悪性形質に関与する(BRD4 is involved in high malignant potential in oral squamous cell carcinoma through the epigenetic regulation). 日本癌学会総会記事. 2018. 77回. 780-780
  • 山本 達郎, Mohamed Osama Abdalla, 中山 秀樹, 斉藤 典子, 中尾 光善. Eleanor非コードRNAは、乳癌の脆弱性に関連するクロマチン構造に影響を及ぼす(Eleanor RNAs affect the chromatin interaction involved in breast cancer fragility). 日本癌学会総会記事. 2018. 77回. 2308-2308
  • Yamamoto Tatsuro, Osama Abdalla Mohamed, Saitoh Noriko, Nakao Mitsuyoshi. ESR1 promoter RNA co-activates Eleanor chromatin domain and distantly located genes in breast cancer. CANCER SCIENCE. 2018. 109. 621
more...
Education (2):
  • 2015 - 2019 Kumamoto University Graduate School of Medical Sciences
  • 2007 - 2013 Kyushu University School of Dentistry
Work history (5):
  • 2024/04 - 現在 Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers Oral & Maxillofacial Surgery Resident
  • 2023/04 - 2024/03 熊本大学 大学院院生命科学研究部 歯科口腔外科学講座
  • 2020/05 - 2023/03 Danish Cancer Society Research Center postdoc
  • 2019/04 - 2020/04 Japanese Foundation for Cancer Research Cancer Institute
  • 2013/04 - 2015/03 Kumamoto University University Hospital
Association Membership(s) (5):
日本口腔科学会 ,  日本口腔腫瘍学会 ,  日本分子生物学会 ,  日本癌学会 ,  日本口腔外科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page